Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party-Reference-Cited by-同舟云学术

Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party

Published:2017-05-22 Issue:8 Volume:52 Page:1120-1125
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Bento L, ,Boumendil A,Finel H,Le Gouill S,Amorim S,Monjanel H,Bouabdallah R,Bay J O,Nicolas-Virelizier E,McQuaker G,Rossi G,Johnson R,Huynh A,Ceballos P,Rambaldi A^ORCID,Bachy E,Malladi R,Orchard K,Pohlreich D,Tilly H,Bonifazi F^ORCID,Poiré X,Guilhot F,Haenel A,Crawley C,Metzner B,Gribben J,Russell N H,Damaj G,Thomson K,Dreger P,Montoto S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201788.pdf

Reference23 articles.

1. Montoto S, Corradini P, Dreyling M, Ghielmini M, Kimby E, López-Guillermo A et al. Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Haematologica 2013; 98: 1014–1021.

2. El-Najjar I, Boumendil A, Luan JJ, Bouabdallah R, Thomson K, Mohty M et al. The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party. Ann Oncol 2014; 25: 2224–2229.

3. Montoto S, Canals C, Rohatiner AZS, Taghipour G, Sureda A, Schmitz N et al. Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia 2007; 21: 2324–2331.

4. Rohatiner AZS, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 2007; 25: 2554–2559.

5. Pettengell R, Schmitz N, Gisselbrecht C, Smith G, Patton WN, Metzner B et al. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol 2013; 31: 1624–1630.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Targeted radionuclide therapy of hematologic malignancies;Nuclear Medicine and Molecular Imaging;2022

3. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma;Blood Advances;2021-12-08

4. 90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma;Cancer Biotherapy and Radiopharmaceuticals;2020-05-01

5. Where does transplant fit in the age of targeted therapies?;Hematology;2019-12-06